Efficacy of celastrol combined with cisplatin in enhancing the apoptosis of U‑2OS osteosarcoma cells via the mitochondrial and endoplasmic reticulum pathways of apoptosis
Authors:
Open Access
- 1 February 2019
- journal article
- research article
- Published by Spandidos Publications in Oncology Letters
- Vol. 17 (3) , 3305-3313
Abstract
Osteosarcoma is a common primary malignant tumor of bone, and the poor prognosis and low 5‑year survival rate have not improved for three decades. The present study aimed to study the effect a combination of celastrol and cisplatin on the human osteosarcoma cell line U‑2OS, and to investigate the mechanism by which celastrol/cisplatin induces the apoptosis of osteosarcoma cells. MTT and Annexin V‑FITC/PI assays were used to evaluate the effects of combined celastrol/cisplatin on growth and apoptosis, respectively, in U‑2OS cells. Morphological changes accompanying cell growth inhibition were observed using a fluorescence microscope. Combination index (CI) analysis was used to evaluate the combinatorial effects of celastrol/cisplatin treatment. Western blotting was used to quantify the expression of apoptosis‑associated proteins. It was identified that celastrol/cisplatin inhibited the growth of U‑2OS cells in a dose‑dependent manner. CI analysis revealed that combined celastrol/cisplatin demonstrated a synergistic effect in U‑2OS cells, with CIs ranging from 0.80 to 0.97 at effect levels from IC10 to IC70. In addition, it was observed that celastrol/cisplatin upregulated the expression of Bcl‑associated X protein, cytochrome c, caspase‑3 and C/EBP homologous protein, and downregulated the expression of Bcl‑2, poly(ADP‑ribose) polymerase, 78 kDa glucose‑regulated protein and caspase‑9, whereas the expression of caspase‑8 remained unchanged. To conclude, celastrol/cisplatin induced apoptosis in U‑2OS cells via the mitochondrial and endoplasmic reticulum pathways, particularly in the former. Celastrol/cisplatin therefore exhibits potential as a novel therapeutic combination for the treatment of osteosarcoma.Keywords
This publication has 34 references indexed in Scilit:
- Osteosarcoma treatment: state of the artCancer and Metastasis Reviews, 2009
- Primary bone osteosarcoma in the pediatric age: State of the artCancer Treatment Reviews, 2006
- Mediators of endoplasmic reticulum stress‐induced apoptosisEMBO Reports, 2006
- Long-term survival after aggressive resection of pulmonary metastases among children and adolescents with osteosarcomaJournal of Pediatric Surgery, 2006
- Connected to Death: The (Unexpurgated) Mitochondrial Pathway of ApoptosisScience, 2005
- Roles of CHOP/GADD153 in endoplasmic reticulum stressCell Death & Differentiation, 2003
- Cisplatin Induces Endoplasmic Reticulum Stress and Nucleus-independent Apoptotic SignalingJournal of Biological Chemistry, 2003
- BCL-2 Improves Oxidative Phosphorylation and Modulates Adenine Nucleotide Translocation in Mitochondria of Cells Harboring Mutant mtDNAJournal of Biological Chemistry, 2003
- Proteases for Cell Suicide: Functions and Regulation of CaspasesMicrobiology and Molecular Biology Reviews, 2000
- BCL-2 family members and the mitochondria in apoptosisGenes & Development, 1999